The largest database of trusted experimental protocols

62 protocols using aspirin

1

Mongolian Gerbil Diet Modifications for Ischemia-Reperfusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seven-week-old male Mongolian gerbils (Meriones unguiculatus) were purchased from DaehanBio (Eumsung, Korea) and acclimated in the animal facility for one week. They were raised in an individual cage at 23 °C, 60% humidity, and a 12 h light/dark cycle. They freely consumed food and water. The study protocols conformed to the National Institute of Health Guidelines and were approved by Hoseo University Animal Care and Use Committee (HSIAUC-18-065).
A semi-purified diet formulation for laboratory rodents as formulated by the American Institute of Nutrition in 1993 (AIN-93) was used to make an experimental diet [18 (link)]. The fat contents in AIN-93 were modified to 43 energy percent, and corn silk water extract (0.05% and 0.2%) was added to the 43 energy percent (En%) fat diet. For the I/R-aspirin, 0.02% aspirin (Bayer, Leverkusen, Germany) was added to the 43 En% fat diet as the positive control (I/R-aspirin). The corn silk water extracts and aspirin were substituted for the cellulose contents. According to the analysis results, each diet was tailored to contain identical total amounts of carbohydrates, protein, and lipids by changing the casein, soybean oil, and cellulose contents. All diets consisted of 43 En% carbohydrates, 17 En% protein, and 40 En% fats. Cellulose (3.4%), mineral (3.5%), and vitamin (1.0%) mixtures were added to all diets.
+ Open protocol
+ Expand
2

Prednisone and Aspirin for Infertile Thyroid Autoimmunity

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 346 euthyroid infertile women with thyroid autoimmunity were divided into two groups—the control group (n = 196) and the treated group (n = 150). Treatment involved orally administered prednisone (Xianju pharmaceutical factory, China) and aspirin (Bayer, Germany) in a daily dose of 10 mg prednisone and 100 mg aspirin. Medication was given starting on the day of embryo transfer and continued until a successful clinical pregnancy was determined by ultrasound. Meanwhile, medication was discontinued if a persistent decline in hCG value occurred.
+ Open protocol
+ Expand
3

Analyzing Vascular Responses with Common Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aspirin was bought from Bayer HealthCare (Wuppertal, Germany). PE, ACh and SNP were bought from Sigma-Aldrich (Steinheim, Germany).
+ Open protocol
+ Expand
4

Comprehensive Thrombosis Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were used in the present study: WSTC (BY-Health Co., Ltd., Batch No. 201701), κ - Carrageenan (Type I, Ekasion, Israel, C1013), trisodium citrate dihydrate (Sinopharm Chemical Reagent Co., Shanghai, China, 20140306), calcein-AM (Invitrogen, Carlsbad, United States, C3100MP), Collagen (Chronolog, Pennsylvania, United States, 385), vWF (Hematologic Technologies, Vermont, United States, HCVWF-0190), ADP (Beijing Techlink Biomedical Technology Co., Ltd., Beijing, China, 20180806A), and aspirin (Bayer Health Care AG, Leverkusen, Germany, 1806210) We also used a rat catecholamine ELISA Kit (BioVision, California, United States, 7F03E44630), a rat vWF ELISA Kit (Shanghai Enzyme-Linked Biotechnology Co., Shanghai, China, 202109), a rat IL-6 ELISA kit (Dakewe biotechnology, Shenzhen, China, 2207-1), Prothrombin time (PT) (lot, 200803901), activated partial thromboplastin time (APTT) (lot 200809200), thrombin time (TT) (lot, 200709501), and fibrinogen (FIB) (lot 210304200), which were purchased from Shanghai Changdao Biotechnology Co., Ltd., Shanghai, China.
+ Open protocol
+ Expand
5

Ticagrelor versus Clopidogrel in Aspirin Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
The patients in the ticagrelor group received 300 mg of aspirin (Bayer, Germany) and 180 mg of ticagrelor (AstraZeneca, UK) once daily, and the patients in the clopidogrel group received 300 mg of aspirin and 600 mg of clopidogrel (Sanofi, France) once daily.
+ Open protocol
+ Expand
6

Inhibiting Platelet Aggregation and Metastasis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For inhibiting platelet aggregation, aspirin (catalog no. J20171021, Bayer) at 30 mg/kg or warfarin (catalog no. H31022123, SINE) at 30 mg/kg was given orally once per day to each mouse for 10 days. Distilled water was used as a control. For metastasis inhibition, a selective GRP75 inhibitor MKT-077 (catalog no. A12388, AdooQ Bioscience) at 15 mg/kg was intraperitoneally injected once per day into each mouse. DMSO (catalog no. MB2505, Meilunbio) was used as a control. For in vitro platelet activation, freshly isolated mouse or human platelets were treated with ADP (catalog no. MB1706, Meilunbio), collagen (catalog no. MB5213, Meilunbio), thrombin (catalog no. MB1368, Meilunbio), ionomycin (catalog no. MB7511, Meilunbio), and arachidonic acid (AA, catalog no. MB6012, Meilunbio). In some experiments, a GRP75 inhibitor MKT-077 (catalog no. A12388, AdooQ Bioscience) at 20 mmol/L was pretreated for 30 minutes prior to agonist stimulation.
+ Open protocol
+ Expand
7

Postoperative Antiplatelet Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients received routine medical and nursing care from community-based physicians and cardiologists after discharge from the hospital. Conventional treatment consisted of the postoperative administration of 100 mg aspirin (Bayer Leverkusen, Germany) once daily for long-term maintenance. Oral ticagrelor (AstraZeneca, Wilmington, DE) 90 mg twice daily was prescribed for one year. Other medications (statins, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, calcium channel blockers, and β-receptor blockers) were given as needed according to the patient’s condition. Routine care comprised post-PCI patient health education and medication management information provided by ward nurses prior to discharge, and regular follow-ups. The routine medical care was in accordance with the guidelines for cardiovascular rehabilitation and secondary prevention in China 2018 simplified edition23 .
+ Open protocol
+ Expand
8

Comparative Onset of Aspirin and Paracetamol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Both of the reported studies were single-center, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, and assessed the comparative onset of action of the fast-release Aspirin tablet in subjects with either postoperative dental pain or sore throat pain. Eligible subjects in either study were randomized in 2:2:1 fashion to either a single dose of Aspirin tablets (Aspirin®, Bayer HealthCare, Germany) equivalent to 1000 mg, paracetamol caplets (Tylenol® Extra Strength, McNeil Consumer Healthcare, US) equivalent to 1000 mg, or placebo. The placebos used in the two studies were Aspirin® matching placebo and Tylenol® Extra Strength matching placebo.
The studies were conducted at investigative sites located in the United States. The studies were conducted in accordance with Good Clinical Practice guidance, and each protocol was approved by an institutional review board (IRB). All participants provided written informed consent.
+ Open protocol
+ Expand
9

Pharmaceutical Ingredient Acquisition Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
DAS (0.2 g/bottle) was obtained from Hidragon Pharma Co., Ltd., Hubei, China, batch number: 1901083. Aspirin was obtained from Bayer Pharma Co., Ltd., Beijing, China, batch number: BJ50050.
+ Open protocol
+ Expand
10

Anti-Inflammatory Effects of RSTF and YPFP

Check if the same lab product or an alternative is used in the 5 most similar protocols
RSTF is composed of seven plant materials, including HMM, FLL, AMK, CR, PCW, OS, and EHH. Yu-ping-feng particle (YPFP) was purchased from Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd. (China); Lanqin oral liquid was from Yangzi River Pharmaceutical Group Co., Ltd. (China); Dexamethasone acetate (DXM) and lipopolysaccharide were purchased from Sigma-Aldrich (USA); aspirin was from Bayer (Germany); ambroxol hydrochloride and atropine were from Aladdin (China), concanavalin (ConA) was from Biosharp (China); tumor necrosis factor (TNF-α) was from Bioss (China). The antibodies of GAPDH, NF-κB, and p65-NF-κB were purchased from Abcam (UK).
All animals were bought from Shanghai SIPPR/BK Experimental Animal Co. They were raised under controlled humidity (55-65%), temperature (22 ± 2°C), and daily light intensity (12 h/12 h light/dark cycles) and fed with water and standard diets ad libitum. Experimental protocols have been approved by the Committee on Laboratory Animal Care of Nanjing University of Chinese Medicine, and all animals were given humane care according to the guidelines of the National Institutes of Health (USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!